Details of the Drug

General Information of Drug (ID: DMNVCY2)

Drug Name

Nexagon

Indication

Disease Entry	ICD 11	Status	REF
Diabetic foot ulcer	BD54	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of CoDa Therapeutics.